Notable Labs LtdOTC Pink - Limited Information:NTBLQ
- LAST PRICE0.0200
- TODAY'S CHANGE (%)-0.0002 (-0.7444%)
- Bid / Lots0.0179/ 100
- Ask / Lots0.0500/ 540
- Open / Previous Close0.0200 / 0.0202
- Day Range
- 52 Week Range
- Volume6,863
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NTBLQ |
|---|---|---|
| 09:32 ET | 2000 | 0.02 |
| 11:48 ET | 4163 | 0.0179 |
| 12:14 ET | 520 | 0.02 |
Oct 23, 2024
*DJ News On Notable Labs Ltd. (NTBL) Now Under NTBLQ, from 5:08PM ET on Wednesday Oct 23, 2024 by Dow Jones
5:08PM ET on Wednesday Oct 23, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Notable Labs Ltd | 194.6K | 0.0x | --- |
Manuka Inc | 235.3K | -0.2x | --- |
Mera Pharmaceuticals Inc | 560.0 | 0.0x | --- |
IMV Inc | 10.0 | 0.0x | --- |
Q BioMed Inc | 14.5K | 0.0x | --- |
Entia Biosciences Inc | 6.7K | 0.0x | --- |
Company Information
Notable Labs Ltd, formerly Vascular Biogenics Ltd, is an Israel-based clinical-stage biopharmaceutical company committed to developing next-generation, targeted medicines for difficult-to-treat medical conditions. The Company has created a pipeline of therapeutics that address cancer and immune-inflammatory diseases with the goal of significantly improving patient outcomes and overcoming the limitations of approved treatments. The Company's product candidates are built off of two platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels, and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications.
Contact Information
- Headquarters
- 320 Hatch DriveFOSTER CITY, CA, United States 94404
- Phone
- 415-851-2410
- Fax
- ---
Executives
- Senior Vice President - Research and Operations
- Eyal Breitbart
- Senior Vice President - Business Operations
- Erez Feige
- Senior Vice President - Clinical Development
- Tami Rachmilewitz
- Senior Vice President - Drug Development & Regulatory Affairs
- Naamit Sher
- Chief Medical Officer
- Glenn Michelson
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $194.6K |
|---|---|
Revenue (TTM) | $313.0K |
Shares Outstanding | 9.7M |
Notable Labs Ltd does not pay a dividend. | |
Beta | 0.90 |
EPS | $-2.47 |
Book Value | $1.68 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -6,493.61% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
